Bank of New York Mellon’s Prestige Consumer Healthcare PBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $15.4M | Buy |
325,275
+13,934
| +4% | +$716K | ﹤0.01% | 1788 |
|
|
2026
Q1 | $18.5M | Sell |
311,341
-13,557
| -4% | -$880K | ﹤0.01% | 1588 |
|
|
2025
Q4 | $20M | Sell |
324,898
-27,202
| -8% | -$1.67M | ﹤0.01% | 1539 |
|
|
2025
Q3 | $22M | Sell |
352,100
-21,056
| -6% | -$1.47M | ﹤0.01% | 1501 |
|
|
2025
Q2 | $29.8M | Buy |
373,156
+649
| +0.2% | +$54.3K | 0.01% | 1299 |
|
|
2025
Q1 | $32M | Sell |
372,507
-12,337
| -3% | -$1.01M | 0.01% | 1232 |
|
|
2024
Q4 | $30.1M | Sell |
384,844
-10,405
| -3% | -$808K | 0.01% | 1326 |
|
|
2024
Q3 | $28.5M | Sell |
395,249
-48,445
| -11% | -$3.43M | 0.01% | 1361 |
|
|
2024
Q2 | $30.5M | Sell |
443,694
-14,683
| -3% | -$995K | 0.01% | 1325 |
|
|
2024
Q1 | $33.3M | Sell |
458,377
-25,395
| -5% | -$1.7M | 0.01% | 1277 |
|
|
2023
Q4 | $29.6M | Sell |
483,772
-6,177
| -1% | -$367K | 0.01% | 1386 |
|
|
2023
Q3 | $28M | Sell |
489,949
-20,905
| -4% | -$1.26M | 0.01% | 1355 |
|
|
2023
Q2 | $30.4M | Sell |
510,854
-23,947
| -4% | -$1.43M | 0.01% | 1310 |
|
|
2023
Q1 | $33.5M | Sell |
534,801
-11,776
| -2% | -$735K | 0.01% | 1251 |
|
|
2022
Q4 | $34.2M | Sell |
546,577
-32,126
| -6% | -$1.84M | 0.01% | 1230 |
|
|
2022
Q3 | $28.8M | Buy |
578,703
+14,381
| +3% | +$796K | 0.01% | 1269 |
|
|
2022
Q2 | $33.2M | Sell |
564,322
-34,350
| -6% | -$1.89M | 0.01% | 1230 |
|
|
2022
Q1 | $31.7M | Sell |
598,672
-14,927
| -2% | -$862K | 0.01% | 1395 |
|
|
2021
Q4 | $37.2M | Sell |
613,599
-40,813
| -6% | -$2.42M | 0.01% | 1347 |
|
|
2021
Q3 | $36.7M | Buy |
654,412
+15,990
| +3% | +$878K | 0.01% | 1345 |
|
|
2021
Q2 | $33.3M | Sell |
638,422
-1,590
| -0.2% | -$76.4K | 0.01% | 1434 |
|
|
2021
Q1 | $28.2M | Sell |
640,012
-72,830
| -10% | -$3.06M | 0.01% | 1500 |
|
|
2020
Q4 | $24.9M | Buy |
712,842
+72,043
| +11% | +$2.56M | 0.01% | 1516 |
|
|
2020
Q3 | $23.3M | Sell |
640,799
-4,835
| -0.7% | -$180K | 0.01% | 1376 |
|
|
2020
Q2 | $24.2M | Sell |
645,634
-19,636
| -3% | -$785K | 0.01% | 1327 |
|
|
2020
Q1 | $24.4M | Sell |
665,270
-23,664
| -3% | -$919K | 0.01% | 1169 |
|
|
2019
Q4 | $27.9M | Buy |
688,934
+22,779
| +3% | +$850K | 0.01% | 1374 |
|
|
2019
Q3 | $23.1M | Sell |
666,155
-17,145
| -3% | -$565K | 0.01% | 1443 |
|
|
2019
Q2 | $21.6M | Sell |
683,300
-773
| -0.1% | -$23K | 0.01% | 1528 |
|
|
2019
Q1 | $20.5M | Sell |
684,073
-22,846
| -3% | -$655K | 0.01% | 1531 |
|
|
2018
Q4 | $21.8M | Buy |
706,919
+35,048
| +5% | +$1.28M | 0.01% | 1414 |
|
|
2018
Q3 | $25.5M | Buy |
671,871
+19,028
| +3% | +$720K | 0.01% | 1461 |
|
|
2018
Q2 | $25.1M | Buy |
652,843
+25,355
| +4% | +$855K | 0.01% | 1469 |
|
|
2018
Q1 | $21.2M | Sell |
627,488
-19,018
| -3% | -$730K | 0.01% | 1540 |
|
|
2017
Q4 | $28.7M | Sell |
646,506
-3,423
| -0.5% | -$156K | 0.01% | 1364 |
|
|
2017
Q3 | $32.6M | Buy |
649,929
+7,521
| +1% | +$384K | 0.01% | 1252 |
|
|
2017
Q2 | $33.9M | Buy |
642,408
+4,110
| +0.6% | +$220K | 0.01% | 1216 |
|
|
2017
Q1 | $35.5M | Sell |
638,298
-207,620
| -25% | -$11.5M | 0.01% | 1191 |
|
|
2016
Q4 | $44.1M | Buy |
845,918
+7,390
| +0.9% | +$357K | 0.01% | 1006 |
|
|
2016
Q3 | $40.5M | Sell |
838,528
-5,101
| -0.6% | -$258K | 0.01% | 1009 |
|
|
2016
Q2 | $46.7M | Sell |
843,629
-100,025
| -11% | -$5.51M | 0.01% | 904 |
|
|
2016
Q1 | $50.4M | Buy |
943,654
+277,437
| +42% | +$13.7M | 0.02% | 857 |
|
|
2015
Q4 | $34.3M | Buy |
666,217
+14,938
| +2% | +$742K | 0.01% | 1048 |
|
|
2015
Q3 | $29.4M | Buy |
651,279
+99,008
| +18% | +$4.68M | 0.01% | 1160 |
|
|
2015
Q2 | $25.5M | Buy |
552,271
+10,256
| +2% | +$449K | 0.01% | 1298 |
|
|
2015
Q1 | $23.2M | Buy |
542,015
+1,459
| +0.3% | +$55.6K | 0.01% | 1387 |
|
|
2014
Q4 | $18.8M | Sell |
540,556
-4,281
| -0.8% | -$142K | ﹤0.01% | 1516 |
|
|
2014
Q3 | $17.6M | Buy |
544,837
+39,675
| +8% | +$1.33M | ﹤0.01% | 1517 |
|
|
2014
Q2 | $17.1M | Buy |
505,162
+10,602
| +2% | +$340K | ﹤0.01% | 1581 |
|
|
2014
Q1 | $13.5M | Buy |
494,560
+5,830
| +1% | +$173K | ﹤0.01% | 1707 |
|
|
2013
Q4 | $17.5M | Buy |
488,730
+10,956
| +2% | +$364K | ﹤0.01% | 1550 |
|
|
2013
Q3 | $14.4M | Sell |
477,774
-136,493
| -22% | -$4.46M | ﹤0.01% | 1614 |
|
|
2013
Q2 | $17.9M | Buy |
+614,267
| New | +$17.3M | 0.01% | 1444 |
|
Other funds holding PBH
RHJA
BTW
LI
N
TCM
Bank of New York Mellon's PBH Position: Q2 2026 in Review
Bank of New York Mellon increased its Prestige Consumer Healthcare (PBH) stake by 4.5% in Q2 2026, buying an estimated $716K and bringing the position to 325,275 shares worth $15.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1788.
Bank of New York Mellon first reported a position in PBH in Q2 2013 and has held it in 53 quarters since. The position peaked at $50.4M in Q1 2016. 148 funds tracked by Wall St. Rank hold PBH as of Q2 2026.
- Bank of New York Mellon held 325,275 shares of Prestige Consumer Healthcare worth $15.4M as of Q2 2026.
- Bank of New York Mellon bought 13,934 Prestige Consumer Healthcare shares in Q2 2026, an estimated $716K.
- Prestige Consumer Healthcare made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #1788 holding.
- Bank of New York Mellon first reported a position in Prestige Consumer Healthcare in Q2 2013 and has held it in 53 quarters since.
- Bank of New York Mellon's Prestige Consumer Healthcare position peaked at $50.4M in Q1 2016.
- 148 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.